Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis

被引:68
作者
Cleland, John G. F. [1 ]
Carubelli, Valentina [1 ]
Castiello, Teresa [1 ]
Yassin, Ashraf [1 ]
Pellicori, Pierpaolo [1 ]
Antony, Renjith [1 ]
机构
[1] Univ Hull, Hull York Med Sch, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England
关键词
Renal dysfunction; Heart failure; Prognosis; Prevalence; Incidence; BLOOD UREA NITROGEN; CARDIAC-RESYNCHRONIZATION THERAPY; CONVERTING-ENZYME-INHIBITORS; SCANDINAVIAN-ENALAPRIL-SURVIVAL; INITIATE LIFESAVING TREATMENT; BRAIN NATRIURETIC PEPTIDE; CYSTATIN-C CONCENTRATION; IN-HOSPITAL MORTALITY; BASE-LINE; CLINICAL CHARACTERISTICS;
D O I
10.1007/s10741-012-9306-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most patients with heart failure have mild or moderate renal dysfunction. This reflects the combined impact of chronic renal parenchymal disease, renal artery disease, renal congestion and hypoperfusion, neuroendocrine and cytokine activation and the effects of treatments for heart failure. Remarkably, with good treatment, the average annual rate of decline in renal function is similar in patients with chronic heart failure and healthy people of a similar age. Urea appears to be a stronger marker of an adverse prognosis than creatinine-based measures of renal function. Recent evidence suggests that minor, transient increases in creatinine in the setting of acute heart failure are not prognostically important but persistent deterioration does indicate a higher mortality. The poor prognosis of patients with worsening renal function ensures that few require renal dialysis but this may change as methods to prevent sudden death improve and new ways are found to control fluid congestion. Reversing renal dysfunction and stopping its progression remain important targets for treatment of heart failure.
引用
收藏
页码:133 / 149
页数:17
相关论文
共 116 条
[1]   Predictors of in-hospital mortality in patients hospitalized for heart failure - Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) [J].
Abraham, William T. ;
Fonarow, Gregg C. ;
Albert, Nancy M. ;
Stough, Wendy Gattis ;
Gheorghiade, Mihai ;
Greenberg, Barry H. ;
O'Connor, Christopher M. ;
Sun, Jie Lena ;
Yancy, Clyde W. ;
Young, James B. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (05) :347-356
[2]   The natural history of renal function following orthotopic heart transplant [J].
Al Aly, Z ;
Abbas, S ;
Moore, E ;
Diallo, O ;
Hauptman, PJ ;
Bastani, B .
CLINICAL TRANSPLANTATION, 2005, 19 (05) :683-689
[3]   Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care [J].
Alehagen, Urban ;
Dahlstrom, Ulf ;
Lindahl, Tomas L. .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (04) :354-360
[4]   Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF) [J].
Allen, Larry A. ;
Metra, Marco ;
Milo-Cotter, Olga ;
Filippatos, Gerasimos ;
Reisin, Leonardo H. ;
Bensimhon, Daniel R. ;
Gronda, Edoardo G. ;
Colombo, Paolo ;
Felker, G. Michael ;
Cas, Livio Dei ;
Kremastinos, Dimitrios T. ;
O'Connor, Christopher M. ;
Cotter, Gadi ;
Davison, Beth A. ;
Dittrich, Howard C. ;
Velazquez, Eric J. .
JOURNAL OF CARDIAC FAILURE, 2008, 14 (09) :777-784
[5]   Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure [J].
Arimoto, T ;
Takeishi, Y ;
Niizeki, T ;
Takabatake, N ;
Okuyama, H ;
Fukui, A ;
Tachibana, H ;
Nozaki, N ;
Hirono, O ;
Tsunoda, Y ;
Miyashita, T ;
Shishido, T ;
Takahashi, H ;
Koyama, Y ;
Kubota, I .
JOURNAL OF CARDIAC FAILURE, 2005, 11 (08) :595-601
[6]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[7]  
Bourantas CV, 2011, HEART FAIL REV, V56, P123
[8]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[9]   Relationship between heart failure treatment and development of worsening renal function among hospitalized patients [J].
Butler, J ;
Forman, DE ;
Abraham, WT ;
Gottlieb, SS ;
Loh, E ;
Massie, BM ;
O'Connor, CM ;
Rich, MW ;
Stevenson, LW ;
Wang, YF ;
Young, JB ;
Krumholz, HM .
AMERICAN HEART JOURNAL, 2004, 147 (02) :331-338
[10]   Usefulness of Cystatin C and Prognosis Following Admission for Acute Heart Failure [J].
Campbell, Catherine Y. ;
Clarke, William ;
Park, Haeseong ;
Haq, Nowreen ;
Barone, Bethany B. ;
Brotman, Daniel J. .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (03) :389-392